Bispecific anti‐CD20/19 CAR‐T—zamtocabtagene autoleucel for relapsed/refractory DLBCL—Interim analysis results of DALY‐II‐USA study Meeting Abstract
| Authors: | Ulrickson, M.; Miklos, D. B.; Maziarz, R. T.; Jacobson, C.; Isufi, I.; Ghosh, M.; Perales, M.; Lunning, M.; Hardy, N. M.; Wijatyk, A.; Ancukiewicz, M.; Nallewar, M.; Coleman, K. C.; Prudner, B. C.; Eromosele, E.; Kaleta, R.; Shah, N. N. |
| Abstract Title: | Bispecific anti‐CD20/19 CAR‐T—zamtocabtagene autoleucel for relapsed/refractory DLBCL—Interim analysis results of DALY‐II‐USA study |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 147 |
| Language: | English |
| DOI: | 10.1002/hon.3163_96 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 096 -- Source: Cinahl |
